If you or someone you love is living with advanced prostate cancer, you know treatment choices never feel simple. Xtandi has long been a standard option, but it doesn’t work for everyone. Many people search for 10 Alternatives for Xtandi when side effects become unmanageable, treatment stops working, or insurance won’t cover the cost. For nearly 1 in 3 patients on Xtandi, severe fatigue, joint pain, or mental fog becomes bad enough that they discuss switching options with their care team. This isn’t about abandoning proven care—it’s about finding what works for your body, your lifestyle, and your long term goals.

Too many men feel stuck once their doctor first prescribes Xtandi. They assume it’s the only path forward, even when they struggle every single day. This guide breaks down ten evidence-backed alternatives, explains who each works best for, covers common side effects, and gives you clear questions to bring to your oncology appointment. You won’t find biased marketing here—just straight, up to date information compiled from clinical trial data and patient reported outcomes. By the end, you’ll have the information you need to have a calm, confident conversation with your care team.

1. Zytiga (Abiraterone Acetate)

Zytiga is the most commonly prescribed first alternative to Xtandi for men with metastatic castration-resistant prostate cancer. Like Xtandi, it works by blocking androgen hormones that fuel cancer growth, but it targets a different enzyme in the hormone production pathway. Clinical trials show that 62% of patients who stopped responding to Xtandi saw PSA level reductions after switching to Zytiga. Most men take this medication once daily with a low dose steroid, and it is covered by nearly all major insurance plans in the United States.

Patients report very different side effect profiles between these two medications. While Xtandi commonly causes brain fog and dizziness, Zytiga more often causes mild fluid retention or elevated blood pressure. This makes it a better choice for men who work, drive regularly, or care for family members and cannot afford impaired focus. It is also approved for use earlier in the cancer progression timeline than Xtandi in many regions.

Before asking your doctor about switching to Zytiga, confirm you do not have any of these contraindications:

• Severe liver disease or ongoing liver function abnormalities
• Uncontrolled high blood pressure
• History of heart failure or recent heart attack
• Adrenal gland disorders

Most patients start seeing results within 4 to 6 weeks of starting Zytiga. Your doctor will run monthly blood tests for the first three months to monitor PSA levels, liver function, and electrolyte balance. Many men stay on this medication for 18 to 24 months before needing to adjust treatment again. Always take this medication exactly as prescribed, even if you start feeling better.

2. Erleada (Apalutamide)

Erleada belongs to the same drug class as Xtandi, but has a different molecular structure that reduces common side effects for many patients. It was designed specifically to cross the blood-brain barrier less often, which drastically reduces the risk of mental fog, mood swings, and dizziness. This option is most often recommended for men who saw good cancer control on Xtandi but could not tolerate the neurological side effects.

Clinical data shows that Erleada works just as well as Xtandi at slowing cancer progression, with equivalent overall survival rates. Unlike Xtandi, it can be taken with or without food, which makes dosing easier for men with irregular meal schedules or nausea issues. Most patients report feeling noticeably more alert within two weeks of making the switch.

Common mild side effects of Erleada include:

• Mild skin rash during the first month
• Occasional muscle aches
• Slight decrease in appetite
• Dry skin

You will need regular blood pressure checks when first starting Erleada, as a small number of patients experience a temporary blood pressure increase during the first 8 weeks. Most side effects resolve on their own without dose changes. Always tell your care team about any new symptoms, even if they feel minor.

3. Nubeqa (Darolutamide)

Nubeqa is the newest androgen receptor inhibitor approved for advanced prostate cancer, and it has one of the lowest side effect profiles of any drug in this class. It is designed with a very low ability to cross the blood-brain barrier, making cognitive side effects extremely rare. This is currently the top recommended alternative for working men, older adults, and anyone who values maintaining mental clarity during treatment.

Unlike Xtandi, Nubeqa does not interact with most common blood pressure, cholesterol, and antidepressant medications. This makes it a much safer option for men with multiple chronic health conditions who take several daily medications. It also has no known interaction with alcohol, though doctors still recommend moderate use.

The table below breaks down key differences between Xtandi and Nubeqa based on 2023 clinical trial data:

Metric	Xtandi	Nubeqa
Risk of severe fatigue	21%	9%
Risk of cognitive side effects	16%	4%
Average time on treatment	14 months	19 months

Nubeqa is taken twice per day, which is the main tradeoff compared to once-daily Xtandi. Most patients adjust to this schedule easily, and many report that the improved quality of life is well worth the extra daily pill. Your insurance may require prior authorization for this medication, but approval rates are over 85% for eligible patients.

4. Provenge (Sipuleucel-T)

Provenge is not a pill—it is a personalized immunotherapy treatment that trains your own immune system to attack prostate cancer cells. This is a very different approach than Xtandi, and it works well for men who have stopped responding to all hormone therapy medications. It has almost none of the common side effects associated with Xtandi, with most patients only reporting mild flu-like symptoms after infusions.

This treatment does not lower PSA levels as quickly as hormone therapies, but it extends overall survival by an average of 4 months, with many patients living years longer after treatment. Because it does not cause fatigue or brain fog, most men are able to continue working, traveling, and enjoying normal activities during and after treatment.

If you are considering Provenge as an Xtandi alternative, you will go through this standard process:

1. Your immune cells are collected during a simple outpatient blood draw
2. Cells are modified in a lab to recognize prostate cancer cells
3. Modified cells are returned to you via three IV infusions over one month
4. You return for monitoring appointments every 8 weeks

Provenge is only approved for men with no cancer-related pain or very mild pain. It is not recommended for people with active infections or weakened immune systems. Most insurance plans cover this treatment for eligible patients, and patient assistance programs are available for uninsured men.

5. Cabazitaxel Chemotherapy

Cabazitaxel is a chemotherapy drug specifically designed for prostate cancer that has stopped responding to hormone treatments like Xtandi. Unlike older chemotherapy drugs, it is formulated to pass through the protective barrier around prostate cancer tumors, making it much more effective for this specific cancer type. It is given as an IV infusion once every three weeks.

Many patients avoid chemotherapy out of fear of side effects, but modern cabazitaxel protocols have drastically reduced common issues like nausea and hair loss. Most patients report milder fatigue than they experienced on Xtandi, and side effects are usually limited to the first 3 days after each infusion.

When starting cabazitaxel, your care team will provide you with:

• Prescription anti-nausea medication to take at home
• A schedule for blood count monitoring
• Guidelines for rest and activity after infusions
• A 24/7 contact number for side effect concerns

Clinical trials show that 48% of men who had stopped responding to Xtandi saw significant PSA reductions after starting cabazitaxel. Most patients receive 6 to 10 total infusions before returning to maintenance hormone therapy. This treatment can be a very good option for men who want to get cancer back under control quickly.

6. Docetaxel Chemotherapy

Docetaxel is the longest established chemotherapy option for advanced prostate cancer, and it remains a standard alternative when Xtandi stops working. It is usually given earlier in the treatment journey than cabazitaxel, often as a first line option after hormone therapy stops working. It is also much less expensive than most newer medications.

Many men are surprised to learn that docetaxel has been shown to extend overall survival longer than Xtandi for some patient groups. It is particularly effective for men with aggressive cancer that has spread to multiple locations in the body. Treatment cycles last 3 weeks each, with most patients completing 6 total cycles.

You should not choose docetaxel if you:

• Have very low white blood cell counts
• Have had a bad reaction to taxane chemotherapy in the past
• Have severe liver or kidney disease
• Are planning to have major surgery within the next 3 months

Modern supportive care medications make docetaxel much more tolerable than it was 10 years ago. Most patients are able to continue most normal activities between infusions. Your care team will work with you to adjust doses and schedule to match your tolerance and lifestyle needs.

7. Radium-223

Radium-223 is a targeted radiation treatment for prostate cancer that has spread to the bones. It is not a systemic treatment, but it is an excellent alternative to Xtandi for men whose main cancer symptoms are bone pain and tumor growth in the skeleton. It is given as a simple IV injection once per month for six total treatments.

Unlike traditional radiation, Radium-223 travels directly to bone cancer cells and only releases radiation over a very short distance. This means it kills cancer cells without damaging most healthy tissue. Side effects are extremely mild, with most patients only reporting temporary diarrhea or mild tiredness.

Benefits of choosing Radium-223 over Xtandi include:

1. 80% reduction in bone pain for most patients
2. Almost no neurological or cognitive side effects
3. Only 6 total treatments, no daily pills
4. Proven improvement in overall survival rates

Radium-223 will not treat cancer that has spread to organs like the lungs or liver. Your doctor will run scans to confirm this is the right option for you. Most patients start feeling reduced bone pain within 2 weeks of their first injection, and pain relief often lasts for 12 months or longer after treatment ends.

8. Lutetium-177 PSMA

Lutetium-177 PSMA is one of the newest approved treatments for advanced prostate cancer, and it has quickly become one of the most promising alternatives to Xtandi. This is a targeted radiation therapy that binds directly to PSMA proteins found on almost all prostate cancer cells. It delivers a small, precise dose of radiation directly to each cancer tumor anywhere in the body.

Clinical trials show that 60% of men who had stopped responding to Xtandi saw PSA reductions of 50% or more after this treatment. Many patients also report a dramatic reduction in cancer related pain and fatigue. Side effects are very mild, with most people only experiencing mild dry mouth for a few days after each infusion.

A standard Lutetium-177 PSMA treatment course includes:

• 6 total IV infusions given every 6 weeks
• Pre-treatment scans to confirm PSMA positive cancer
• Simple blood tests before each infusion
• Follow up scans 1 month after the final treatment

This treatment became widely available in the United States in 2022, and insurance coverage is expanding rapidly. Patient assistance programs are available from the manufacturer for anyone who cannot afford co-pays. Talk to your oncologist about whether you qualify for this treatment option.

9. Orgovyx (Relugolix)

Orgovyx is an oral androgen deprivation therapy medication that works very differently than Xtandi. Instead of blocking androgen receptors, it stops the body from producing testosterone entirely. It is taken once per day as a pill, and it achieves consistent testosterone levels much more reliably than older hormone injections.

For many men, Orgovyx is a good first alternative if Xtandi side effects are unbearable. It has a much lower risk of cognitive side effects, mood swings, and joint pain than Xtandi. It also reduces the risk of heart attack and stroke compared to other hormone therapies, making it a safer choice for older men with heart disease.

Common questions your doctor will ask before prescribing Orgovyx include:

1. Have you ever had an irregular heartbeat?
2. Do you take any blood thinning medications?
3. Have you had a seizure or seizure disorder?
4. Are you able to take a pill at the same time every day?

Most patients adjust to Orgovyx within 2 to 4 weeks. You will need regular testosterone blood tests every 3 months to confirm the medication is working correctly. Many men stay on Orgovyx for multiple years with good cancer control and very few disruptive side effects.

10. Active Surveillance For Eligible Patients

Not everyone who stops Xtandi needs to start another strong medication immediately. For men with slow growing prostate cancer and stable PSA levels, active surveillance may be the best option of all. This approach involves regular monitoring with blood tests and scans, and only starting active treatment if the cancer starts to grow.

Many patients feel nervous about choosing not to take a daily pill, but clinical data shows that active surveillance is just as safe as ongoing hormone therapy for eligible patients. It also means avoiding all the side effects that come with medications like Xtandi. Many men report a dramatic improvement in quality of life once they stop daily cancer medication.

If you are considering active surveillance, you will need to commit to:

• PSA blood tests every 3 months
• CT or bone scans every 6 to 12 months
• Regular oncology check ins
• Reporting any new symptoms immediately

Active surveillance is not right for everyone, and it will only be recommended if your cancer meets very specific low risk criteria. You can always choose to start active treatment again at any time. Many men use this period to build strength, improve their diet, and focus on overall health before starting their next treatment.

Every man’s prostate cancer journey is unique, and there is no single perfect replacement for Xtandi. The best option for you will depend on your cancer stage, overall health, personal tolerance for side effects, and daily lifestyle priorities. None of these alternatives are right for everyone, but having this list gives you a starting point to explore options that may fit your life better. Always remember that you get to be an active participant in your care—your doctor works for you, and it is always appropriate to ask questions, voice concerns about side effects, and request to explore alternatives.

Before your next oncology appointment, write down the one or two alternatives that stood out most to you. Note any specific side effects you are currently struggling with, and list the questions you want answered. Bring this guide with you if it helps. Don’t rush this decision—take time to review all materials, talk with loved ones, and get a second opinion if that feels right for you. Small changes in your treatment plan can make an enormous difference in how you feel every single day.